66) Acid phosphatase activity increased signif |
67) Acid phosphatase activity was inhibited by |
68) a higher expression of tartrate-resistant acid phosphatase (TRAP) and the receptor a |
69) n apparent increase in tartrate resistant acid phosphatase (TRAP) positive staining |
70) Tartrate-resistant acid phosphatase (TRAP)-positive cell numb |
71) The serum level of tartrate-resistant acid phosphatase 5b, a marker of osteoclas |
72) gnificantly stimulated tartrate-resistant acid phosphatase activity in co-culture wi |
73) Sensitivity of acid phosphatase from Vigna aconitifolia s |
74) lored molybdate as a potent inhibitor for acid phosphatase in comparison with other |
75) dehydrogenase, glutathione peroxidase and acid phosphatase were not affected by GO t |
76) markably, even though informative nucleic acid is absent, prions may undergo rapid a |
77) Polysialic acid is an α2,8-linked N-acetylneuraminic |
78) Attachment to sialic acid is mediated by receptor binding prote |
79) gradation of the pharmaceutical clofibric acid is presented. |
80) Polysialic acid is produced by two complementary sial |
81) , but not the only, carrier of polysialic acid is the neural cell adhesion molecule |
82) Tannic acid is water-soluble polyphenol that is p |
83) Zoledronic acid is widely used in the treatment of os |
84) cyclododecane-N,N',N″,N‴-tetra acetic acid-DPhe1,Tyr3-octreotate) is used for di |
85) walked on a flat surface after zoledronic acid was administered for 2 years, 10 mont |
86) mited number of subjects, topical fusidic acid was found to delay wound healing by p |
87) adiation another conformer, II, of oxamic acid was generated, with cis orientation o |
88) Zoledronic acid was immediately discontinued in this |
89) Tannic acid was intraperitoneally injected at a d |
90) The D/L ratio of aspartic acid was obtained by HPLC technique in a t |
91) ridyl, H2Pyri = 3,5- Pyridinedicarboxylic acid) was synthesized and characterized by |
92) Permeation of itraconazole from stearic acid-SLNs was higher than that obtained wi |
93) (PRP) as the growth factor and hyaluronic acid (HA) as the scaffold. |
94) m efficacy and tolerability of hyaluronic acid (HA) for the treatment of knee pain d |
95) Humic acid (HA) has been implicated as a contrib |
96) from male donors delivered in hyaluronic acid (HA) on papain-induced OA in the knee |
97) This study explored the effects of humic acid (HA) on the toxicity of ZnO nanoparti |
98) on of topical cream containing hyaluronic acid (HA) sodium salt. |
|